Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Zoetis Income After Taxes 2011-2025 | ZTS

Zoetis annual/quarterly income after taxes history and growth rate from 2011 to 2025. Income after taxes can be defined as earnings or losses after income tax expense but before minority interest, extraordinary items, discontinued operations, preferred dividends and accounting changes have been accounted for.
  • Zoetis income after taxes for the quarter ending March 31, 2025 was $631M, a 5.34% increase year-over-year.
  • Zoetis income after taxes for the twelve months ending March 31, 2025 was $2.528B, a 5.86% increase year-over-year.
  • Zoetis annual income after taxes for 2024 was $2.496B, a 6.67% increase from 2023.
  • Zoetis annual income after taxes for 2023 was $2.34B, a 10.85% increase from 2022.
  • Zoetis annual income after taxes for 2022 was $2.111B, a 3.79% increase from 2021.
  
Zoetis Annual Income After Taxes
(Millions of US $)
2024 $2,496
2023 $2,340
2022 $2,111
2021 $2,034
2020 $1,636
2019 $1,500
2018 $1,424
2017 $862
2016 $819
2015 $339
2014 $587
2013 $503
2012 $436
2011 $248
2010 $111
Zoetis Quarterly Income After Taxes
(Millions of US $)
2025-03-31 $631
2024-12-31 $581
2024-09-30 $692
2024-06-30 $624
2024-03-31 $599
2023-12-31 $523
2023-09-30 $596
2023-06-30 $670
2023-03-31 $551
2022-12-31 $460
2022-09-30 $528
2022-06-30 $529
2022-03-31 $594
2021-12-31 $413
2021-09-30 $552
2021-06-30 $511
2021-03-31 $558
2020-12-31 $358
2020-09-30 $479
2020-06-30 $376
2020-03-31 $423
2019-12-31 $384
2019-09-30 $433
2019-06-30 $371
2019-03-31 $312
2018-12-31 $345
2018-09-30 $347
2018-06-30 $382
2018-03-31 $350
2017-12-31 $80
2017-09-30 $296
2017-06-30 $247
2017-03-31 $239
2016-12-31 $154
2016-09-30 $237
2016-06-30 $224
2016-03-31 $204
2015-12-31 $20
2015-09-30 $190
2015-06-30 $-36
2015-03-31 $165
2014-12-31 $126
2014-09-30 $167
2014-06-30 $139
2014-03-31 $155
2013-12-31 $104
2013-09-30 $131
2013-06-30 $128
2013-03-31 $140
2012-12-31 $-10
2012-09-30 $161
2012-06-30 $173
2012-03-31 $112
2011-12-31
2010-12-31
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $74.020B $9.256B
Zoetis Inc. is a leader in the animal health space with a focus on both livestock and companion animals in seven major product categories: vaccines, anti-infectives, parasiticides, dermatology, other pharmaceutical products, medicated feed additives and animal health diagnostics. Zoetis has a diversified business, which caters to eight core species ' cattle, swine, poultry, fish and sheep (collectively, livestock) and dogs, cats and horses (collectively, companion animals). It directly markets its products to veterinarians and livestock producers. The outstanding growth rate in the companion animal medicines, vaccines and diagnostics sector is being driven by economic development, related increases in disposable income and a rise in pet ownership and spending on pet care.Zoetis has been working on strengthening its product portfolio through acquisitions and deals.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $87.311B 32.75
Daiichi Sankyo, - (DSNKY) Japan $51.315B 26.11
Takeda Pharmaceutical (TAK) Japan $46.678B 9.28
Sandoz Group AG (SDZNY) Switzerland $21.655B 0.00
Summit Therapeutics (SMMT) United States $19.042B 0.00
Merck (MKKGY) Germany $17.125B 12.55
United Therapeutics (UTHR) United States $14.201B 12.56
Shionogi (SGIOY) Japan $14.121B 14.15
Neurocrine Biosciences (NBIX) United States $12.137B 41.57
IPSEN (IPSEY) France $9.821B 0.00
Orion OYJ (ORINY) Finland $9.323B 25.21
Corcept Therapeutics (CORT) United States $8.145B 66.22
Stevanato Group S.p.A (STVN) Italy $6.917B 42.30
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Madrigal Pharmaceuticals (MDGL) United States $6.030B 0.00
Grifols, S.A (GRFS) Spain $5.659B 0.00
Ionis Pharmaceuticals (IONS) United States $5.303B 0.00
Ono Pharmaceutical (OPHLF) Japan $4.875B 14.83
Soleno Therapeutics (SLNO) United States $3.843B 0.00
Catalyst Pharmaceuticals (CPRX) United States $3.030B 10.61
Hypermarcas (HYPMY) Brazil $2.873B 18.90
Crinetics Pharmaceuticals (CRNX) United States $2.762B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.285B 12.36
BioCryst Pharmaceuticals (BCRX) United States $2.258B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.910B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.785B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.705B 0.00
Indivior (INDV) United States $1.630B 6.92
Evotec AG (EVO) Germany $1.518B 0.00
ARS Pharmaceuticals (SPRY) United States $1.436B 0.00
Guardian Pharmacy Services (GRDN) United States $1.401B 0.00
Dyne Therapeutics (DYN) United States $1.330B 0.00
Ocular Therapeutix (OCUL) United States $1.106B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.101B 22.03
Harrow (HROW) United States $0.966B 0.00
Ardelyx (ARDX) United States $0.950B 0.00
Collegium Pharmaceutical (COLL) United States $0.947B 5.11
Avadel Pharmaceuticals (AVDL) Ireland $0.876B 0.00
Enliven Therapeutics (ELVN) United States $0.785B 0.00
Cronos Group (CRON) Canada $0.771B 0.00
Akebia Therapeutics (AKBA) United States $0.767B 0.00
Xeris Biopharma Holdings (XERS) United States $0.755B 0.00
AleAnna (ANNA) United States $0.675B 0.00
Elite Pharmaceuticals (ELTP) United States $0.568B 0.00
USANA Health Sciences (USNA) United States $0.566B 12.30
KalVista Pharmaceuticals (KALV) United States $0.558B 0.00
Xencor (XNCR) United States $0.552B 0.00
Regulus Therapeutics (RGLS) United States $0.548B 0.00
Bioventus (BVS) United States $0.536B 13.60
Relay Therapeutics (RLAY) United States $0.489B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.464B 0.00
Zevra Therapeutics (ZVRA) United States $0.462B 0.00
Altimmune (ALT) United States $0.447B 0.00
Siga Technologies (SIGA) United States $0.434B 9.07
Oruka Therapeutics (ORKA) United States $0.428B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.421B 0.00
CytoDyn (CYDY) United States $0.406B 0.00
Tourmaline Bio (TRML) United States $0.398B 0.00
Verve Therapeutics (VERV) United States $0.382B 0.00
Organogenesis (ORGO) United States $0.377B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.351B 9.48
Savara (SVRA) United States $0.335B 0.00
Heron Therapeutics (HRTX) United States $0.288B 0.00
Nature's Sunshine Products (NATR) United States $0.272B 25.14
Tonix Pharmaceuticals Holding (TNXP) United States $0.271B 0.00
Aquestive Therapeutics (AQST) United States $0.253B 0.00
MediWound (MDWD) Israel $0.230B 0.00
ProKidney (PROK) United States $0.214B 0.00
Journey Medical (DERM) United States $0.181B 0.00
Wellgistics Health (WGRX) United States $0.180B 0.00
Nanobiotix S.A (NBTX) France $0.180B 0.00
Esperion Therapeutics (ESPR) United States $0.163B 0.00
OmniAb (OABI) United States $0.162B 0.00
Avita Medical (RCEL) United States $0.160B 0.00
Profound Medical (PROF) Canada $0.159B 0.00
4D Molecular Therapeutics (FDMT) United States $0.158B 0.00
Aclaris Therapeutics (ACRS) United States $0.138B 0.00
Liminatus Pharma (LIMN) $0.132B 0.00
Aldeyra Therapeutics (ALDX) United States $0.132B 0.00
Inhibikase Therapeutics (IKT) United States $0.132B 0.00
Nektar Therapeutics (NKTR) United States $0.126B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.124B 0.00
Protara Therapeutics (TARA) United States $0.122B 0.00
Innate Pharma SA (IPHYF) France $0.122B 0.00
Lyell Immunopharma (LYEL) United States $0.121B 0.00
Korro Bio (KRRO) United States $0.120B 0.00
Larimar Therapeutics (LRMR) United States $0.117B 0.00
Achieve Life Sciences (ACHV) Canada $0.110B 0.00
VAXART, INC (VXRT) United States $0.105B 0.00
Cassava Sciences (SAVA) United States $0.103B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.101B 0.00
OptiNose (OPTN) United States $0.097B 0.00
Cardiol Therapeutics (CRDL) Canada $0.096B 0.00
Fractyl Health (GUTS) United States $0.096B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.090B 0.00
Lexeo Therapeutics (LXEO) United States $0.090B 0.00
Inotiv (NOTV) United States $0.088B 0.00
Arch Biopartners (ACHFF) Canada $0.084B 0.00
Galectin Therapeutics (GALT) United States $0.083B 0.00
Champions Oncology (CSBR) United States $0.083B 13.61
Cumberland Pharmaceuticals (CPIX) United States $0.080B 59.33
Pyxis Oncology (PYXS) United States $0.077B 0.00
ESSA Pharma (EPIX) Canada $0.071B 0.00
Unicycive Therapeutics (UNCY) United States $0.071B 0.00
Dominari Holdings (DOMH) United States $0.069B 0.00
Vivani Medical (VANI) United States $0.068B 0.00
Nutriband (NTRB) United States $0.067B 0.00
Surrozen (SRZN) United States $0.066B 0.00
Assertio Holdings (ASRT) United States $0.065B 0.00
Telomir Pharmaceuticals (TELO) United States $0.063B 0.00
Metagenomi (MGX) United States $0.062B 0.00
Context Therapeutics (CNTX) United States $0.061B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.053B 0.00
Gain Therapeutics (GANX) United States $0.052B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.051B 0.00
Century Therapeutics (IPSC) United States $0.048B 0.00
PMV Pharmaceuticals (PMVP) United States $0.047B 0.00
Mural Oncology (MURA) Ireland $0.045B 0.00
Prelude Therapeutics (PRLD) United States $0.045B 0.00
NRx Pharmaceuticals (NRXP) United States $0.045B 0.00
Karyopharm Therapeutics (KPTI) United States $0.039B 0.00
Avalo Therapeutics (AVTX) United States $0.039B 0.00
Iterum Therapeutics (ITRM) Ireland $0.038B 0.00
ElectroCore (ECOR) United States $0.036B 0.00
Acrivon Therapeutics (ACRV) United States $0.034B 0.00
FibroGen (FGEN) United States $0.032B 0.00
Rafael Holdings (RFL) United States $0.032B 0.00
SCYNEXIS (SCYX) United States $0.028B 0.00
PolyPid (PYPD) Israel $0.026B 0.00
China SXT Pharmaceuticals (SXTC) China $0.024B 0.00
Enlivex Therapeutics (ENLV) Israel $0.024B 0.00
CASI Pharmaceuticals (CASI) China $0.023B 0.00
Tempest Therapeutics (TPST) United States $0.023B 0.00
Relmada Therapeutics (RLMD) United States $0.022B 0.00
Jupiter Neurosciences (JUNS) United States $0.021B 0.00
Natural Alternatives (NAII) United States $0.020B 0.00
BioVie (BIVI) United States $0.019B 0.00
Lipocine (LPCN) United States $0.019B 0.00
Mannatech (MTEX) United States $0.018B 0.00
TherapeuticsMD (TXMD) United States $0.017B 0.00
DURECT (DRRX) United States $0.016B 0.00
SHINECO (SISI) China $0.015B 0.00
VYNE Therapeutics (VYNE) United States $0.015B 0.00
ProPhase Labs (PRPH) United States $0.015B 0.00
Ernexa Therapeutics (ERNA) United States $0.015B 0.00
GlycoMimetics (GLYC) United States $0.015B 0.00
MEI Pharma (MEIP) United States $0.014B 0.00
Cosmos Health (COSM) United States $0.013B 0.00
Vivos Therapeutics (VVOS) United States $0.013B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.013B 0.00
Ainos (AIMD) United States $0.013B 0.00
BioLineRx (BLRX) Israel $0.012B 0.00
Scienture Holdings (SCNX) United States $0.012B 0.00
Minerva Neurosciences (NERV) United States $0.010B 1.82
Talphera (TLPH) United States $0.010B 0.00
Mangoceuticals (MGRX) United States $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Phio Pharmaceuticals (PHIO) United States $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Incannex Healthcare (IXHL) Australia $0.008B 0.00
Carisma Therapeutics (CARM) United States $0.008B 0.00
Traws Pharma (TRAW) United States $0.008B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.007B 0.00
Citius Pharmaceuticals (CTXR) United States $0.007B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
Klotho Neurosciences (KLTO) United States $0.007B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.006B 0.00
Lyra Therapeutics (LYRA) United States $0.006B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.006B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
Indaptus Therapeutics (INDP) United States $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Plus Therapeutics (PSTV) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Alaunos Therapeutics (TCRT) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.004B 0.00
PainReform (PRFX) Israel $0.004B 0.00
Aditxt (ADTX) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.003B 0.00
Conduit Pharmaceuticals (CDT) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00